focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
If the Affimer binding site binds to a part of the spike protein that is not affected by mutation, then variants will not affect S&S.
If the binding site is altered, it is probable that S&S would be affected and it could even be that the test could be completely ineffective. In such an event, it has been stated that a new version of the Affimer could be attached in weeks - much faster than the time needed to make a new antibody.
I recall a French variant that wasn't picked up by PCR due to a mutation. It didn't stop us using PCR, we just made a new set of primers.
Nice link troll.
"Several states have complained that the kits - which are supposed to test for the presence of antibodies against the coronavirus - are malfunctioning."
"...antibodies..."
Fool
MBGR: are you attempting to deny the existence of Avacta's LFT for which the CV has been completed and the paperwork for the CE marking is being filled out, followed by commercialisation early next month?
Do you think that there will be NO orders for a test with near 100% sensitivity and specificity? i.e. far higher than the competition, all packaged up in a test designed for AN, rather than tagged on after the fact.
Travel use them as there isn't (yet) a real option. But, to give one example, just yesterday someone posted a link to an Indian flight with 52+ passengers that had tested negative with PCR in the three days leading up to the flight who on quarantine had covid. The fact that PCR takes so long means that people need to be tested too long before it matters and they have the opportunity to catch it between testing and the flight.
PCR is used currently to double-check positives (which was a climb-down in policy I recall) as people (rightly) do not have faith that a positive (using current LFTs) means you have it. PCR can give false positives. With further trials, we'll see what Abakta's FP rate it.
PCR - to test for Covid - is declining and it going to decline further. It is slow, expensive, oversensitive and requires technicians and equipment.
Why the need for a UK validation process?
The chances of finding positive, fresh sample is pretty darn low, so should take an absolute age.
CE marking applies in the UK for a couple of years hence.
The mythical £8B tender doesn't need a PD validation, just something similar will do. Are we nearly there yet?
This sort of anecdotal evidence spreads like wildfire.
It will take some skillful promotion along the lines of "Sorry about that Innova crap, here's one that really works. Honest."
About as easy to advertise as an anti-wrinkle cream that actually reduces wrinkles.
MrA the flipside is that if a boss said to an employee that they're doing an Innova test and the employee asked for an AN test, the boss would just tell them to just do the Innova test.
In your spare time when you're not trolling the AVCT board telling us all that our money coming in doesn't justify our market cap, do you troll the TSLA board telling them that their money coming in doesn't justify their market cap?